These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 8097877

  • 1. Estrogen and progesterone receptor and c-erbB-2 oncoprotein analysis in pure in situ breast carcinoma: an immunohistochemical study.
    Wilbur DC, Barrows GH.
    Mod Pathol; 1993 Mar; 6(2):114-20. PubMed ID: 8097877
    [Abstract] [Full Text] [Related]

  • 2. [Steroid hormone receptors in mammary carcinoma. Immunohistochemical detection and prognostic significance].
    Reiner A, Neumeister B, Reiner G, Jakesz R, Kolb R, Schemper M, Spona J.
    Zentralbl Pathol; 1991 Mar; 137(3):233-41. PubMed ID: 1657132
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of oestrogen and progesterone receptors, and c-erbB-2 in carcinoma of the breast in Trinidadian women.
    Rao AV, Mohammed WA, Ragoonanan C, Omo-Igbinomwanhia NE.
    West Indian Med J; 2002 Mar; 51(1):4-9. PubMed ID: 12089875
    [Abstract] [Full Text] [Related]

  • 4. Correlation of clinical, pathological status, hormone receptor and C-erbB-2 oncoprotein in breast cancer patients.
    Aryandono T, Harijadi, Ghozali A.
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():600-6. PubMed ID: 10895217
    [Abstract] [Full Text] [Related]

  • 5. Differences in the pathologic and molecular features of intraductal breast carcinoma between younger and older women.
    Rodrigues NA, Dillon D, Carter D, Parisot N, Haffty BG.
    Cancer; 2003 Mar 15; 97(6):1393-403. PubMed ID: 12627502
    [Abstract] [Full Text] [Related]

  • 6. Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies.
    Moinfar F, Okcu M, Tsybrovskyy O, Regitnig P, Lax SF, Weybora W, Ratschek M, Tavassoli FA, Denk H.
    Cancer; 2003 Aug 15; 98(4):703-11. PubMed ID: 12910513
    [Abstract] [Full Text] [Related]

  • 7. Mammographically-detected ductal in situ carcinoma of the breast analyzed with a new classification. A study of 127 cases: correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity.
    Zafrani B, Leroyer A, Fourquet A, Laurent M, Trophilme D, Validire P, Sastre-Garau X.
    Semin Diagn Pathol; 1994 Aug 15; 11(3):208-14. PubMed ID: 7831532
    [Abstract] [Full Text] [Related]

  • 8. [Combined surgery and radiotherapy in the treatment of ductal carcinoma in situ of the breast: preliminary results of the Hungarian multicenter prospective randomised study].
    Polgár C, Orosz Z, Kahán Z, Gábor G, Jani N, Cserni G, Hadijev J, Kulka J, Sulyok Z, Boross G, Lázár G, László Z, Diczházi C, Udvarhelyi N, Szabó E, Péntek Z, Major T, Fodor J.
    Magy Onkol; 2008 Sep 15; 52(3):269-77. PubMed ID: 18845497
    [Abstract] [Full Text] [Related]

  • 9. Expression of c-erbB-2 in node negative breast cancer does not correlate with estrogen receptor status, predictors of hormone responsiveness, or PCNA expression.
    Kolár Z, Murray PG, Zapletalová J.
    Neoplasma; 2002 Sep 15; 49(2):110-3. PubMed ID: 12088102
    [Abstract] [Full Text] [Related]

  • 10. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR, Abd-Elwahed SR, Abdulwahed AR.
    Cell Biol Int; 2008 Jun 15; 32(6):698-707. PubMed ID: 18296077
    [Abstract] [Full Text] [Related]

  • 11. Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.
    Ioachim E, Kamina S, Demou A, Kontostolis M, Lolis D, Agnantis NJ.
    Anticancer Res; 1999 Jun 15; 19(3A):2133-9. PubMed ID: 10470161
    [Abstract] [Full Text] [Related]

  • 12. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer.
    McCann AH, Dervan PA, O'Regan M, Codd MB, Gullick WJ, Tobin BM, Carney DN.
    Cancer Res; 1991 Jun 15; 51(12):3296-303. PubMed ID: 1674898
    [Abstract] [Full Text] [Related]

  • 13. The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone.
    Cornfield DB, Palazzo JP, Schwartz GF, Goonewardene SA, Kovatich AJ, Chervoneva I, Hyslop T, Schwarting R.
    Cancer; 2004 Jun 01; 100(11):2317-27. PubMed ID: 15160334
    [Abstract] [Full Text] [Related]

  • 14. Breast carcinoma in women 35 years and younger: a pathological study.
    Fernandopulle SM, Cher-Siangang P, Tan PH.
    Pathology; 2006 Jun 01; 38(3):219-22. PubMed ID: 16753742
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers.
    Leal C, Henrique R, Monteiro P, Lopes C, Bento MJ, De Sousa CP, Lopes P, Olson S, Silva MD, Page DL.
    Hum Pathol; 2001 May 01; 32(5):487-93. PubMed ID: 11381366
    [Abstract] [Full Text] [Related]

  • 17. Biochemically estrogen receptor-negative, progesterone receptor-positive breast carcinoma. Immunocytochemical hormone receptors and prognostic factors.
    Keshgegian AA.
    Arch Pathol Lab Med; 1994 Mar 01; 118(3):240-4. PubMed ID: 8135626
    [Abstract] [Full Text] [Related]

  • 18. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
    Ariga N, Moriya T, Suzuki T, Kimura M, Ohuchi N, Satomi S, Sasano H.
    Anticancer Res; 2000 Mar 01; 20(2B):1101-8. PubMed ID: 10810403
    [Abstract] [Full Text] [Related]

  • 19. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM, Albarracin C, Diaz LK, Symmans FW, Edgerton ME, Hwang RF, Sneige N.
    Am J Surg Pathol; 2008 Apr 01; 32(4):544-52. PubMed ID: 18300793
    [Abstract] [Full Text] [Related]

  • 20. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
    Suthipintawong C, Wejaranayang C, Vipupinyo C.
    J Med Assoc Thai; 2008 Dec 01; 91(12):1779-84. PubMed ID: 19133508
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.